select medical holdings corp - SEM

SEM

Close Chg Chg %
14.81 0.05 0.30%

Closed Market

14.86

+0.05 (0.30%)

Volume: 461.23K

Last Updated:

Dec 24, 2025, 12:59 PM EDT

Company Overview: select medical holdings corp - SEM

SEM Key Data

Open

$14.76

Day Range

14.73 - 14.89

52 Week Range

11.65 - 20.83

Market Cap

$1.83B

Shares Outstanding

123.82M

Public Float

106.44M

Beta

1.28

Rev. Per Employee

N/A

P/E Ratio

17.09

EPS

$0.87

Yield

167.90%

Dividend

$0.06

EX-DIVIDEND DATE

Nov 12, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

1.33M

 

SEM Performance

1 Week
 
-1.13%
 
1 Month
 
-4.20%
 
3 Months
 
17.41%
 
1 Year
 
-21.85%
 
5 Years
 
-44.96%
 

SEM Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 5
Full Ratings ➔

About select medical holdings corp - SEM

Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following business segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, and Outpatient Rehabilitation. The Critical Illness Recovery Hospital segment serves patients with debilitating injuries and rehabilitation needs that cannot be adequately cared for in a medically intensive environment, such as a skilled nursing facility. The Rehabilitation Hospital segment provides physical medicine, as well as rehabilitation programs and services, which serve to optimize patient health, function, and quality of life. The Outpatient Rehabilitation segment offers physical, occupational, and speech rehabilitation services through its clinics. The company was founded by Robert A. Ortenzio and Rocco A. Ortenzio in 1996 and is headquartered in Mechanicsburg, PA.

SEM At a Glance

Select Medical Holdings Corp.
4714 Gettysburg Road
Mechanicsburg, Pennsylvania 17055-5036
Phone 1-717-972-1100 Revenue 5.19B
Industry Hospital/Nursing Management Net Income 214.04M
Sector Health Services Employees 44,100
Fiscal Year-end 12 / 2025
View SEC Filings

SEM Valuation

P/E Current 17.091
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 11.377
Price to Sales Ratio 0.469
Price to Book Ratio 1.446
Price to Cash Flow Ratio 4.70
Enterprise Value to EBITDA 13.232
Enterprise Value to Sales 1.04
Total Debt to Enterprise Value 0.501

SEM Efficiency

Revenue/Employee 117,621.429
Income Per Employee 4,853.469
Receivables Turnover 6.315
Total Asset Turnover 0.78

SEM Liquidity

Current Ratio 1.043
Quick Ratio 1.043
Cash Ratio 0.061

SEM Profitability

Gross Margin 9.462
Operating Margin 5.107
Pretax Margin 3.369
Net Margin 4.126
Return on Assets 0.95
Return on Equity 4.253
Return on Total Capital 1.44
Return on Invested Capital 1.255

SEM Capital Structure

Total Debt to Total Equity 160.843
Total Debt to Total Capital 61.663
Total Debt to Total Assets 48.223
Long-Term Debt to Equity 147.421
Long-Term Debt to Total Capital 56.517
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Select Medical Holdings Corp - SEM

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
6.20B 6.33B 6.66B 5.19B
Sales Growth
+12.16% +2.08% +5.22% -22.16%
Cost of Goods Sold (COGS) incl D&A
5.49B 5.81B 5.94B 4.70B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
202.65M 205.82M 208.74M 142.87M
Depreciation
173.15M 174.82M 177.04M 141.27M
Amortization of Intangibles
29.50M 31.00M 31.70M 1.60M
COGS Growth
+11.63% +5.80% +2.32% -20.95%
Gross Income
716.72M 527.55M 723.30M 490.78M
Gross Income Growth
+16.41% -26.39% +37.10% -32.15%
Gross Profit Margin
+11.55% +8.33% +10.85% +9.46%
2021 2022 2023 2024 5-year trend
SG&A Expense
146.97M 153.03M 170.19M 225.87M
Research & Development
- - - -
-
Other SG&A
146.97M 153.03M 170.19M 225.87M
SGA Growth
+6.48% +4.12% +11.21% +32.71%
Other Operating Expense
- - - -
-
Unusual Expense
(144.03M) (28.77M) 12.92M 25.44M
EBIT after Unusual Expense
713.77M 403.28M 540.18M 239.47M
Non Operating Income/Expense
51.97M 12.00M 121.58M 127.89M
Non-Operating Interest Income
- - - 5.35M
-
Equity in Earnings of Affiliates
44.43M 26.41M 40.81M 63.90M
Interest Expense
136.02M 154.70M 279.40M 192.59M
Interest Expense Growth
-11.10% +13.73% +80.61% -31.07%
Gross Interest Expense
136.02M 154.70M 279.40M 192.59M
Interest Capitalized
- - - -
-
Pretax Income
629.72M 260.58M 382.36M 174.77M
Pretax Income Growth
+37.95% -58.62% +46.73% -54.29%
Pretax Margin
+10.15% +4.11% +5.74% +3.37%
Income Tax
129.77M 62.55M 82.63M 44.78M
Income Tax - Current - Domestic
124.72M 55.03M 98.74M 75.65M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
5.05M 7.52M (16.12M) (30.87M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
44.43M 26.41M 40.81M 63.90M
Other After Tax Income (Expense)
(13.44M) (5.61M) (8.77M) (2.32M)
Consolidated Net Income
486.51M 192.42M 290.96M 127.67M
Minority Interest Expense
97.72M 39.03M 56.24M 64.51M
Net Income
388.79M 153.38M 234.72M 63.15M
Net Income Growth
+55.45% -60.55% +53.03% -73.09%
Net Margin Growth
+6.27% +2.42% +3.52% +1.22%
Extraordinaries & Discontinued Operations
- - - 150.88M
-
Discontinued Operations
- - - 150.88M
-
Net Income After Extraordinaries
388.79M 153.38M 234.72M 214.04M
Preferred Dividends
- - - -
-
Net Income Available to Common
388.79M 153.38M 234.72M 214.04M
EPS (Basic)
2.985 1.2307 1.9066 1.6568
EPS (Basic) Growth
+54.90% -58.77% +54.92% -13.10%
Basic Shares Outstanding
130.25M 124.63M 123.11M 129.19M
EPS (Diluted)
2.985 1.2307 1.9066 1.6568
EPS (Diluted) Growth
+54.90% -58.77% +54.92% -13.10%
Diluted Shares Outstanding
130.25M 124.63M 123.11M 129.19M
EBITDA
772.39M 580.34M 761.85M 407.77M
EBITDA Growth
+13.04% -24.86% +31.28% -46.48%
EBITDA Margin
+12.45% +9.16% +11.43% +7.86%

Snapshot

Average Recommendation BUY Average Target Price 18.40
Number of Ratings 5 Current Quarters Estimate 0.232
FY Report Date 12 / 2025 Current Year's Estimate 1.229
Last Quarter’s Earnings 0.23 Median PE on CY Estimate N/A
Year Ago Earnings 0.94 Next Fiscal Year Estimate 1.315
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 6 6 6 6
Mean Estimate 0.23 0.44 1.23 1.32
High Estimates 0.24 0.49 1.25 1.44
Low Estimate 0.22 0.40 1.21 1.20
Coefficient of Variance 4.44 9.42 1.11 7.87

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 4 4 5
OVERWEIGHT 0 0 0
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Select Medical Holdings Corp in the News